PharmEasy

PharmEasy is one of India’s leading digital healthcare and e-pharmacy platforms, providing online medicine delivery, diagnostic testing, teleconsultation, and healthcare services through a technology-driven ecosystem. Founded in 2015 and headquartered in Mumbai, the company operates under API Holdings and has emerged as a major player in India’s health-tech sector by simplifying access to medicines and healthcare services across urban and semi-urban markets.

The platform enables users to order prescription medicines, book lab tests, access health packages, consult doctors online, and purchase wellness and healthcare products through its mobile app and website. PharmEasy has built an extensive supply-chain and partner-pharmacy network across India, allowing it to provide doorstep delivery and diagnostic services at scale. The company strengthened its market position further through the acquisition of Thyrocare, one of India’s leading diagnostic chains, enabling deeper integration between diagnostics and digital healthcare services.

Over the years, PharmEasy has become one of India’s most recognized health-tech startups, backed by major investors including Prosus, Temasek, TPG Growth, and B Capital. The company has focused heavily on affordability, digital convenience, and healthcare accessibility while competing with platforms such as Tata 1mg, Apollo 24/7, and Netmeds. Although the company faced valuation corrections and delayed IPO plans amid broader startup market challenges, PharmEasy continues to expand its healthcare ecosystem and remains a significant player in India’s rapidly growing online healthcare and pharmacy industry.